Evidence map›Paper›PMID 9819392›Full record

ArticleMolecular and cellular biology1998

Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation.

R W Roof, M D Haskell, B D Dukes, N Sherman, M Kinter, S J Parsons

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 139 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. p190RhoGAPs, theCells · 2019
    Review
  7. Review
  8. Article
  9. PseudoGTPase domains in p190RhoGAP proteins: a mini-review.Biochemical Society transactions · 2018
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

R W RoofDepartment of Microbiology and Cancer Center, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
M D Haskell
B D Dukes
N Sherman
M Kinter
S J Parsons
Virginia Department of Health · US

Funding

The Src Target, p190RhoGAP, in Growth RegulationR01CA039438 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PARSONS, SARAH J · 1985 to 2008
$2.0M
NCI NIH HHS CA39438NCI NIH HHS R01 CA039438
6 · The paper itself

Abstract

p190 RhoGAP is a 190-kDa protein that stably associates with p120 RasGAP and regulates actin dynamics through members of the Rho family of small GTPases. Previous studies have indicated a direct relationship between levels of p190 tyrosine phosphorylation, the extent and kinetics of epidermal growth factor (EGF)-induced actin rearrangements, and EGF-induced cell cycle progression, suggesting that p190 links Ras-mediated mitogenic signaling with signaling through the actin cytoskeleton. Determining which tyrosine residues in p190 are phosphorylated, what factors regulate phosphorylation of these sites, and what effect tyrosine phosphorylation has on p190 function is key to understanding the role(s) that p190 may play in these processes. To begin investigating these questions, we used biochemical approaches to characterize the number and relative levels of in vivo-phosphorylated tyrosine residues on endogenous p190 from C3H10T1/2 murine fibroblasts. Only two tryptic phosphopeptides containing phosphotyrosine (p-Tyr), a major site, identified as Y1105, and a minor, unidentified site, were detected. Phosphorylation of Y1105, but not the minor site, was modulated in vivo to a greater extent by overexpression of c-Src than by the EGF receptor and was efficiently catalyzed by c-Src in vitro, indicating that Y1105 is a selective and preferential target of c-Src both in vitro and in vivo. In vitro and in vivo coprecipitation analysis using glutathione S-transferase (GST) fusion proteins containing wild-type and Y1105F variants of the p190 middle domain, variants of full-length p190 ectopically expressed in COS-7 cells, and endogenous p190 and p120 in C3H10T1/2 cells revealed that p190 could bind to p120 in the presence and absence of p190 tyrosine phosphorylation. p-Tyr-independent complexes comprised 10 to 20% of the complexes formed in the presence of p-Tyr. Mutation of Y1105 from Tyr to Phe resulted in complete loss of p-Tyr-dependent complex formation, indicating that p-Y1105 was the sole p-Tyr residue mediating binding to p120. These studies describe a specific mechanism by which c-Src can regulate p190-p120 association and also document a significant role for p-Tyr-independent means of p190-p120 binding.

Indexed as

Guanine Nucleotide Exchange FactorsAmino Acid SequenceAnimalsCell LineCSK Tyrosine-Protein KinaseDNA-Binding ProteinsGTPase-Activating ProteinsMass SpectrometryMiceMolecular Sequence DataNuclear ProteinsPeptide MappingPhosphopeptidesPhosphoproteinsPhosphorylationPhosphotyrosineArhgap35 protein, mouseArhgap5 protein, mouseCSK Tyrosine-Protein KinaseDNA-Binding ProteinsGTPase-Activating ProteinsGuanine Nucleotide Exchange FactorsNuclear ProteinsPhosphopeptidesPhosphoproteinsPhosphotyrosineProteinsProtein-Tyrosine Kinasesras-GRF1Rasgrf1 protein, mouseras GTPase-Activating ProteinsRepressor Proteinssrc-Family Kinases

Identifiers

PMID9819392
PMCPMC109287
OpenAlexW1913395666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.